The aim of the present study was to investigate whether enzyme chondroitinase ABC (ChABC) treatment influences the phenotype of neural progenitor cells (NPCs) derived from injured rat spinal cord. Adult as well as fetal spinal cords contain a pool of endogenous neural progenitors cells, which play a key role in the neuroregenerative processes following spinal cord injury (SCI) and hold particular promise for therapeutic approaches in CNS injury or neurodegenerative disorders. In our study we used in vitro model to demonstrate the differentiation potential of NPCs isolated from adult rat spinal cord after SCI, treated with ChABC.
Disorders of the central nervous system are a major concern in modern human society. Spinal cord injury (SCI) is a major cause of paralysis. Currently, there are no effective therapies to reverse this disabling condition. In the mammals, the adult neural tissues have limited regenerative capability. Neural progenitor cells (NPCs) refer to the multipotent cells that give rise to the cells of the nervous system. They are found in both embryonic and adult tissues, in mammalian brain and spinal cord (Horner et al. 2000 , Alvarez-Buylla et al. 2001 , differentiating into neurons, astrocytes, oligodendrocytes. When NPCs are cultured in the presence of growth factors, they form neurospheres which are free-floating colonies of cells primarily composed of progenitor cells and <1 % stem cells (Morshead et al. 1994) . NPCs play an important role in the neuroregenerative processes following spinal cord injury (SCI) and NPCs have been explored as a potential therapy for SCI (Willerth and Sakiyama-Elbert 2008) . It is well docomented that SCI initiates a chain of events that lead to cell death, scarring and the loss of function. The initial trauma injures cells, plasma endothelin-1 levels are elevated (Guo et al. 2010) , the damaged cells release toxins that cause necrosis of the cells above and below the injury site. Subsequent events include the formation of a cystic cavity at the injury site, which becomes surrounded by a glial scar, composed of mainly reactive astrocytes (Fawcet and Asher 1999) . The main class of inhibitory molecules produced by reactive astrocytes after SCI are chondroitin sulfate proteoglycans (CSPGs) (Fok-Seang et al. 1995) . CSPGs are inhibitory molecules enriched in the extracellular matrix in the CNS that are upregulated at the injury site in vivo and their manipulation may be useful for treatment of human spinal injuries (Fitch and Silver 1997 , Fawcet and Asher 1999 , Tang et al. 2003 . Furthermore, ChABC application promotes regeneration and restores function after SCI (Bradbury et al. 2002 , Yick et al. 2003 , Matsui and Oohira 2004 , Sandvig et al. 2004 , Huang et al. 2006 Vol. 60 Therefore, degradation of CSPG using enzyme chondroitinase ABC (ChABC) might impact the NPCs phenotype development at the lesion site.
Spinal progenitor cells were harvested from spinal cords of adult male Wistar rats weighting 290-320 g. All experiments conformed to the Slovak Law for Animal Protection No. 23/2009, which is transposed from the Directive 86/609/EEC on the protection of animals used for experimental and other scientific purposes and were approved by the Institutional Ethical Committee for animal research. Trauma was performed by modified balloon-compression technique (Vanicky et al. 2001) under isoflurane vapor inhalation anesthesia (1.5-3 %). A rectal probe was inserted, and body temperature was maintained at 37-38 °C using a heating pad. Animals were divided into 3 groups: i) naive rats, (n=5); ii) rats after SCI with IT application of saline (SCI+saline), (n=5); and iii) rats after SCI with intrathecal application (IT) of ChABC (10 U/ml, protease free, C3667, SigmaAldrich) (SCI+ChABC), (n=5). The IT delivery of ChABC or saline was performed at day 1 and 2 after SCI, according to IT application previously described (Cizkova et al. 2010) . At the fifth day after SCI, NPCs were isolated from spinal cord. The dissected tissue of spinal cords was cut into small pieces and transferred to the papain dissociation system according to the Worthington kit protocol, to isolate neural stem cells. Harvested single cells were cultivated in Nunc T25 culture flasks, grown in proliferation culture medium composed of Dulbecco's Modified Eagle Medium (DMEM) and Ham's F12 (1/1 v/v) supplemented with 5 mg/ml streptomycin, 5 IU/ml penicillin, B27, N2 and growth factors FGF-2, bEGF (both 20 ng/ml) to allow for the formation of neurospheres (37 ºC, 5 % CO 2 ). The arisen neurospheres that were formed within one week of in vitro cultivation, were dissociated by mechanical trituration and differentiated in growth factors free differentiation medium containing fetal bovine serum. The cultures were grown for additional 10 days to induce differentiation and then fixed for immunocytochemical detection in 15 wells of the 24-well plate per each group, 5 individual wells per each antibody, altogether 45 wells were analyzed. Immunocytochemistry was performed by applying primary antibodies for detection of astrocytes/ anti-mouse GFAP (1:500), oligodendrocytes/anti-mouse RIP (1:1000) and neurons/anti-rabbit MAP2 (1:1000) ( Table 1) followed with corresponding secondary fluorescence (FITC, CY3) antibodies.
To determine the number of differentiated progeny (identified by specific cell phenotype) generated, the positive cells were counted as a percentage of total DAPI+ nuclei in 10 random fields. Data are presented as mean ± S.E.M. Statistical differences between groups were evaluated with paired Student´s t-test. Using immunocytochemistry by applying specific antibodies, the populations of neurons (MAP 2), astrocytes (GFAP) and oligodendrocytes (RIP) were analyzed (Fig. 1) . The numbers of differentiated cells in SCI+saline vs. SCI+ChABC rats were: neurons 21.59 % vs. 24.57 %, astrocytes 11.10 % vs. 21.23 %, oligodendrocytes 26.45 % vs. 34.81 %. In naive rats we observed following values: neurons 28.47 %, astrocytes 15.1 % and oligodendrocytes 37.38 %. In the present study we used an in vitro model demonstrating the differentiation potential of NPCs isolated from adult rat spinal cord after SCI and treatment with ChABC. Based on cultivation strategies and immunocytochemical analyses for cell markers (MAP 2, GFAP, RIP) we were able to characterize the occurrence and representation of different cell types: neurons, astrocytes and oligodendrocytes derived from injured adult rat spinal cord treated with ChABC. These findings indicate, that the impact of SCI resulted in a decrease of NPCs phenotypes in general. On the contrary, the ChABC treatment caused an opposite effect, elevated numbers of surviving neurons and oligodendroglial cells, reaching almost control values, with acceleration of astrocytes. However, no significant differences between experimental and control groups were detected. These data partially corresponds with results of Sirko et al. (2007) who systematically addressed the question of whether ChABC affects stem cell behavior. They showed that the selective elimination of CSPGs with ChABC, both in vivo and in vitro, reduces NSCs proliferation and the differentiation of radial glia to neurons, whereas it favors the maturation of astrocytes. Removal of CSPGs severely impairs neurospheres formation, self-renewal and the generation of their neuronal progeny. This implies a role of CSPGs in the regulation of growth and differentiation factors for NPCs. Although, our data confirm that ChABC delivery may enhance NPCs, particularly astrocytes and oligodendroglia, we did not detect differences in the ability of neurospheres formation between both groups. This may be due to the limited capacity of adult spinal cord tissue for neurosphere formation when compared with embryonic tissue (Davis and Temple 1994) .
